Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Parallel-Group Extension Study to Evaluate the Safety of Two Doses of DR-3001 in Women With Overactive Bladder

NCT00782769 is registered in ClinicalTrials.gov with Duramed Research as lead sponsor.

NCT NCT00782769
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00782769 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Parallel-Group Extension Study to Evaluate the Safety of Two Doses of DR-3001 in Women With Overactive Bladder
Lead sponsor
Duramed Research
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2008
Completion date
July 31, 2010
Enrollment
240 (actual)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder